American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 415-418 , March 2010

Blood Pressure Control in CKD Patients: Why Do We Fail to Implement the Guidelines?

  • Gavin J. Becker, MD

      Affiliations

    • The Royal Melbourne Hospital, Victoria, Australia
    • Corresponding Author InformationAddress correspondence to Gavin J. Becker, MD, Department of Nephrology, The Royal Melbourne Hospital, Grattan St, Parkville, Victoria 3050, Australia
    • ,
  • David C. Wheeler, MD

      Affiliations

    • University College London Medical School, England, United Kingdom

References 

  1. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45:1119–1124
  2. De Nicola L, Minutolo R, Chiodini P, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69:538–545
  3. Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121:332–340
  4. Thilly N, Boini S, Kessler M, Briancon S, Frimat L. Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR Study (AVantagE de la Nephroprotection dans l'Insuffisance Renale). Nephrol Dial Transplant. 2009;24:934–939
  5. Muntner P, Anderson A, Charleston J, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55(3):441–451
  6. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  7. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004;43(suppl 1):S1–S290
  8. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals—part 1: blood pressure measurement in humans—a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716
  9. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567
  10. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pressure control through provider education, provider alerts, and patient education—a cluster randomized trial. Ann Intern Med. 2006;145:165–175
  11. Jafar TH, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med. 2009;151:593–601
  12. Andersen MJ, Khawandi W, Agarwal R. Pathogenesis and treatment of kidney disease and hypertension—home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994–1001
  13. Wühl E, Hadtstein C, Mehls O, Schaefer F, et al. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res. 2004;55:492–497
  14. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–411
  15. Keenan K, Hayen A, Neal BC, Irwig L. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ. 2009;338:1492–1498

PII: S0272-6386(09)01588-1

doi: 10.1053/j.ajkd.2009.12.013

American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 415-418 , March 2010

Article Tools